🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to evaluate safety/ reactogenicity of ...
Status
Completed
Location
Floridian Clinical Research LLC
Start Date
2023-05-17
Trial ID
NCT05901636
Treatments Being Tested
This is a multicentre study in which women were planned to receive either t...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-02-16
Trial ID
NCT00294047
Treatments Being Tested
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-01-17
Trial ID
NCT00586339
Treatments Being Tested
Cervical cancer is the second most common cancer among women worldwide. App...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-01
Trial ID
NCT00481767
Treatments Being Tested
AdimrSC-2f is a subunit protein-based vaccine produced using the baculoviru...
Status
Completed
Location
University Gadjah Mada Academic Hospital
Start Date
2022-01-03
Trial ID
NCT05104489
Treatments Being Tested
The purpose of this study is to find the optimal dose of AllerT that should...
Status
Completed
Location
Inflamax Research Inc.
Start Date
2014-10
Trial ID
NCT02271009
The purpose of this study is to evaluate the efficacy of the Norovirus (NoV...
Status
Completed
Location
Great Lakes Naval Station
Start Date
2016-06-14
Trial ID
NCT02669121
Treatments Being Tested
This is a prospective phase I study to evaluate the safety, tolerability an...
Status
Completed
Location
Centro de Pesquisa Clinica do Instituto da Criança do hospital das Clinicas da Faculdade de Medicina da USP
Start Date
2010-01
Trial ID
NCT01111968
The present trial is a phase I first in human, double blind, parallel and p...
Status
Completed
Location
NIHR/Wellcome Trust Imperial Clinical Research Facility, Hammersmith Hospital
Start Date
2016-07
Trial ID
NCT02787109
Treatments Being Tested
Dose-response trial with a cocktail of recombinant major allergens of Timot...
Status
Completed
Location
Prof. Dr. med. Ludger Klimek
Start Date
2007-09
Trial ID
NCT00666341